Status:
COMPLETED
Factors Affecting Mortality in Covid-19 Disease
Lead Sponsor:
Melike Cengiz
Conditions:
COVID-19 Pneumonia
Mortality
Eligibility:
All Genders
18+ years
Brief Summary
The coronavirus disease-19 (COVID-19), defined by the reporting of pneumonia cases of unknown etiology at the end of 2019 in Wuhan, China, has spread worldwide, causing millions of deaths. Despite the...
Detailed Description
It was designed as a retrospective cohort study in which patients with a diagnosis of COVID-19 hospitalized in the ICU between 11 March 2020 and 31 March 2022 were included. Patients aged ≥18 years w...
Eligibility Criteria
Inclusion
- Patients aged ≥18 years with a confrmed diagnosis of the severe acute respiratory syndrome coronavirus-2 infection by a positive real-time reverse-transcription polymerase chain reaction test
Exclusion
- Patients whose SARS-CoV-2 RT-PCR test was negative
- Chest computed tomography findings or symptoms were not compatible with COVID-19
Key Trial Info
Start Date :
May 11 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 15 2022
Estimated Enrollment :
619 Patients enrolled
Trial Details
Trial ID
NCT06043115
Start Date
May 11 2022
End Date
December 15 2022
Last Update
September 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Akdeniz University School of Medicine, Department of Anesthesiology and Intensive Care, Turkey
Antalya, Turkey (Türkiye)